Key facts
- It has raised $500K; the latest was Early Stage VC in Jun 2025.
- Notable investors include Y Combinator, Kima Ventures, Rebel Fund.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Kaelio
- ·The full record, as it builds
Funding rounds
No funding rounds for Kaelio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kaelio
Developer of analytics agents designed to improve decision-making in the healthcare field. The company's platform unifies clinical, operational, and financial data for hospitals, health systems, and health plans to receive AI-driven insights, identify operational risks, and gain actionable recommendations for enhancing clinical outcomes and financial performance, enabling healthcare organizations to overcome the challenge of unmanageable dashboards and resource limitations.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2024
- Employees
- 2
- Website
- kaelio.com/
- Ownership
- Privately Held (backing)
Kaelio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kaelio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kaelio in its N-PORT filings yet. We sweep new filings monthly.